Symbol="BCYC"
AssetType="Common Stock"
Name="Bicycle Therapeutics Ltd"
Description="Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, is developing a class of drugs for diseases that are not served by existing treatments. The company is headquartered in Cambridge, the United Kingdom."
CIK="1761612"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="B900 BABRAHAM RESEARCH CAMPUS, CAMBRIDGE, GB"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="760101000"
EBITDA="-126249000"
PERatio="None"
PEGRatio="None"
BookValue="8.1"
DividendPerShare="0"
DividendYield="0"
EPS="-4.25"
RevenuePerShareTTM="0.521"
ProfitMargin="0"
OperatingMarginTTM="-8.46"
ReturnOnAssetsTTM="-0.184"
ReturnOnEquityTTM="-0.433"
RevenueTTM="15499000"
GrossProfitTTM="-67146000"
DilutedEPSTTM="-4.25"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.268"
AnalystTargetPrice="52.36"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="61.69"
PriceToBookRatio="3.139"
EVToRevenue="39.3"
EVToEBITDA="-6.12"
Beta="0.731"
num_52WeekHigh="33.49"
num_52WeekLow="18.8"
num_50DayMovingAverage="24.25"
num_200DayMovingAverage="24.99"
SharesOutstanding="30043500"
DividendDate="None"
ExDividendDate="None"
symbol="BCYC"
open="25.32"
high="26.17"
low="25.14"
price="25.44"
volume="89058.00"
latest_trading_day="2023-07-10"
previous_close="25.30"
change="0.14"
change_percent="0.5534%"
aroon_positive_momentum_days="34"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="34"
Volume_recent_avg="268994"
Change_recent_avg="-0.02"
Delta_recent_avg="1.27"
Variance_recent_avg="0.63"
Change_ratio_recent_avg="-0.13"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="34"
Aroon_momentum_negative="66"
image_negative_thumbnail_id_1="140"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0036.jpeg"
image_negative_thumbnail_id_2="172"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0004.jpeg"
image_neutral_thumbnail_id_1="574"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0025.jpeg"
image_neutral_thumbnail_id_2="551"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0048.jpeg"
image_positive_thumbnail_id_1="977"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0139.jpeg"
image_positive_thumbnail_id_2="632"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0076.jpeg"
image_professor_thumbnail_id_1="1188"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
image_professor_thumbnail_id_2="1182"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
